The central position of estrogen in the physiological and pharmacological control of bone resorption is now challenged by evidence from mouse genetics of estrogen-independent control by pituitary FSH.
References
Albright, F. Smith, P.H. & Richardson, A.M. JAMA 116, 2465–2474 (1941).
Sun, L. et al. Cell 125, 247–260 (2006).
Danilovich, N. et al. Endocrinology 141, 4295–4308 (2000).
Manolagas, S.C. & Jilka, R.L. N. Engl. J. Med. 332, 305–311 (1995).
Eghbali-Fatourechi, G. et al. J. Clin. Invest. 111, 1221–1230 (2003).
Burger, H.G. et al. Recent Prog. Horm. Res. 57, 257–275 (2002).
Welt, C.K. et al. J. Clin. Endocrinol. Metab. 84, 105–111 (1999).
Gaddy-Kurten, D. et al. Endocrinology 143,74–83 (2002).
Perrien, D.S. et al. J. Clin. Endocrinol. Metab. 91, 1848–1854 (2006).
Ebeling, P.R. J. Clin. Endocrinol. Metab. 91, 1669–1670 (2006).
Vural, F. et al. Maturitas 52, 147–153 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martin, T., Gaddy, D. Bone loss goes beyond estrogen. Nat Med 12, 612–613 (2006). https://doi.org/10.1038/nm0606-612
Issue Date:
DOI: https://doi.org/10.1038/nm0606-612
- Springer Nature America, Inc.
This article is cited by
-
A comparative study of mechanical strain, icariin and combination stimulations on improving osteoinductive potential via NF-kappaB activation in osteoblast-like cells
BioMedical Engineering OnLine (2015)
-
Reproductive Hormones and Bone
Current Osteoporosis Reports (2010)